Latest Breaking News On - Neil cashman - Page 1 : comparemela.com

ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS

ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesNeil cashmanPromis neurosciences inc nasdaqPromis neurosciences incBiological chemistryInteraction between pathogenic proteinsTreatment targetNeurosciences incNeil warmaChief executive officerChief scientific officerCollective coordinatesDisease specific epitopesPrivate securities litigation reform actAnnual report

ProMIS Neurosciences : Corporate Overview -March 29, 2024 at 07:41 am EDT

NASDAQ: PMN Corporate Presentation Legal Disclaimers This slide deck may contain certain.

Maggie shafmasterJohanne kaplanPatrick kirwinEugene williamsNeil cashmanLarry altstielWilliam wymanJosh mandel brehmGavin malenfantDavid wishartDan geffkenPromis neurosciences incLeadership teamAlzheimer associationPioneering solutions for neurodegenerative diseasesWorld health organization

ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine

ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMarco pradoNeil cashmanJoel wattsScott napperTanz centre for researchPromis neurosciences incDepartment of biochemistryWeston family foundationUniversity of british columbiaInfectious disease organizationUniversity of saskatchewanCanada researchAmerican academy of neurologyUniversity of western ontario

ProMIS Neurosciences Inc : ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine

ProMIS Neurosciences Inc : ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesJoel wattsScott napperStefan klotterMarco pradoNeil cashmanCanada researchExchange commissionAmerican academy of neurologyDepartment of biochemistryUniversity of british columbiaUniversity of torontoInfectious disease organizationWeston family foundationPromis neurosciences inc

ProMIS Neurosciences Issues Letter to Shareholders

ProMIS Neurosciences Issues Letter to Shareholders
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNeil cashmanPromis neurosciences incIssues letterNeurosciences issues letterChief executive officerNeil warmaChief scientific officerIntellectual propertyIndependent dataSafety monitoring boardSingle ascending doseMultiple ascending doseCollective coordinatesDisease specific epitopes